1-3 of 3
Kojo S. Elenitoba-Johnson, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Constitutive Activation of FRAP/mTOR Pathway in Pediatric Anaplastic Large Cell Lymphomas: Potential Role as a Therapeutic Target.

Megan S. Lim, MD, PhD, Charles Seiler, Sheryl Tripp, Sherrie L. Perkins, MD PhD, Mitchell S. Cairo, MD, Kojo S. Elenitoba-Johnson, MD
Journal: Blood
Blood (2006) 108 (11): 290.
https://doi.org/10.1182/blood.V108.11.290.290
Published: 2006
Journal Articles

NPM-ALK Promotes Cell Cycle Progression through Activation of JNK and c-Jun in Anaplastic Large Cell Lymphoma.

Vasiliki Leventaki, MD, Elias Drakos, MD, Megan Lim, MD, Kojo S. Elenitoba-Johnson, MD, Francois-Xavier Claret, PhD, L. Jeffrey Medeiros, MD, George Z. Rassidakis, MD,PhD
Journal: Blood
Blood (2006) 108 (11): 2057.
https://doi.org/10.1182/blood.V108.11.2057.2057
Published: 2006
Journal Articles

Aberrant Expression of IL-2R in Pediatric Anaplastic Large Cell Lymphoma: Cellular and Proteomic Analysis of Denileukin Diftitox (ONTAK) as a Potential Therapeutic Agent.

Megan S. Lim, MD, PhD, Jaqueline Tygeson, Charles Seiler, David K. Crockett, Prakash Satwani, MD, Sherrie L. Perkins, MD, PhD, Mitchell S. Cairo, MD, Kojo S. Elenitoba-Johnson, MD
Journal: Blood
Blood (2006) 108 (11): 2051.
https://doi.org/10.1182/blood.V108.11.2051.2051
Published: 2006